Comment diagnostiquer une maladie vasculaire ?

Le diagnostic repose sur l'examen clinique, l'imagerie et des tests sanguins.

Quels tests sont utilisés pour les maladies vasculaires ?

Les échographies, IRM, angiographies et tests de stress sont couramment utilisés.

Les marqueurs sanguins sont-ils utiles ?

Oui, des marqueurs comme le cholestérol et la protéine C-réactive aident au diagnostic.

Quand consulter un spécialiste ?

Consultez un spécialiste si vous avez des symptômes persistants ou des antécédents familiaux.

Les antécédents médicaux influencent-ils le diagnostic ?

Oui, les antécédents de maladies cardiovasculaires sont cruciaux pour le diagnostic.

Quels sont les symptômes courants des maladies vasculaires ?

Douleurs thoraciques, engourdissements, fatigue, et troubles de la circulation sont fréquents.

Comment reconnaître une mauvaise circulation sanguine ?

Les signes incluent des jambes froides, des douleurs lors de l'effort et des engourdissements.

Les maladies vasculaires causent-elles des douleurs ?

Oui, elles peuvent provoquer des douleurs, notamment dans les membres ou la poitrine.

Les symptômes varient-ils selon le type de maladie ?

Oui, les symptômes dépendent du type de maladie vasculaire, comme l'AVC ou l'athérosclérose.

Les symptômes sont-ils toujours présents ?

Non, certains patients peuvent ne présenter aucun symptôme jusqu'à une complication grave.

Comment prévenir les maladies vasculaires ?

Adoptez un mode de vie sain, faites de l'exercice et contrôlez votre pression artérielle.

Le tabagisme influence-t-il les maladies vasculaires ?

Oui, le tabagisme augmente considérablement le risque de maladies vasculaires.

Une alimentation équilibrée est-elle importante ?

Oui, une alimentation riche en fruits, légumes et oméga-3 aide à prévenir ces maladies.

Le stress a-t-il un impact sur la santé vasculaire ?

Oui, le stress chronique peut contribuer à des problèmes vasculaires et cardiaques.

Les examens réguliers sont-ils nécessaires ?

Oui, des bilans de santé réguliers aident à détecter précocement les problèmes vasculaires.

Quels traitements sont disponibles pour les maladies vasculaires ?

Les traitements incluent des médicaments, des interventions chirurgicales et des changements de mode de vie.

Les médicaments sont-ils efficaces ?

Oui, des médicaments comme les anticoagulants et les statines sont souvent prescrits.

Quand une intervention chirurgicale est-elle nécessaire ?

Une chirurgie est envisagée en cas de blocages graves ou de complications menaçant la vie.

Les changements de mode de vie aident-ils ?

Oui, une alimentation saine, l'exercice et l'arrêt du tabac améliorent la santé vasculaire.

Les traitements sont-ils personnalisés ?

Oui, les traitements sont adaptés en fonction des besoins et des conditions de chaque patient.

Quelles sont les complications des maladies vasculaires ?

Les complications incluent les AVC, les crises cardiaques et l'insuffisance circulatoire.

Les maladies vasculaires peuvent-elles entraîner une amputation ?

Oui, des cas graves de maladie vasculaire périphérique peuvent nécessiter une amputation.

Comment les maladies vasculaires affectent-elles le cœur ?

Elles peuvent provoquer des maladies coronariennes, entraînant des douleurs thoraciques et des crises cardiaques.

Les complications sont-elles réversibles ?

Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles.

Les complications augmentent-elles le risque de décès ?

Oui, les complications graves des maladies vasculaires augmentent le risque de mortalité.

Quels sont les principaux facteurs de risque ?

Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité.

L'âge influence-t-il le risque de maladies vasculaires ?

Oui, le risque augmente avec l'âge, surtout après 50 ans.

Le diabète est-il un facteur de risque ?

Oui, le diabète augmente le risque de maladies vasculaires et de complications associées.

Le sexe joue-t-il un rôle dans le risque ?

Oui, les hommes ont généralement un risque plus élevé de maladies vasculaires que les femmes.

L'hérédité influence-t-elle le risque ?

Oui, des antécédents familiaux de maladies cardiovasculaires augmentent le risque.

Maladies vasculaires - Informations médicales vérifiées

Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.

27 May 2024

DOI: 10.1186/s12885-024-12383-7 PMID: 38802765

Radiotherapy interruption (RTI) prolongs the overall total treatment time and leads to local control loss in many cancers, but it is unclear in esophageal cancer. We aimed to evaluate the influence of... A total of 299 patients with esophageal squamous cell carcinoma from 2017 to 2019 were retrospectively analyzed to investigate the effect of RTI on OS, PFS, and LRFS. The delayed time of radiotherapy ... The 3-year OS, PFS, and LRFS rates were 53.0%, 42.0%, and 48.0%, respectively. The univariate and multivariate analyses showed that the delayed time > 3 days was an independent adverse prognostic fact... There was a significant correlation between delayed time and local control of esophageal cancer. The delayed time for more than 3 days might decrease the survival outcome, and increase the local recur...

Humans Esophageal Neoplasms Retrospective Studies Male Female +12 autres

Online adaptive planning methods for intensity-modulated radiotherapy.

11 05 2023

DOI: 10.1088/1361-6560/accdb2 PMID: 37068488

Online adaptive radiation therapy aims at adapting a patient's treatment plan to their current anatomy to account for inter-fraction variations before daily treatment delivery. As this process needs t...

Humans Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy Dosage Artificial Intelligence

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.

08 2023

DOI: 10.1016/S1470-2045(23)00265-6 PMID: 37423227

Most newly diagnosed oropharyngeal and hypopharyngeal cancers are treated with chemoradiotherapy with curative intent but at the consequence of adverse effects on quality of life. We aimed to investig... DARS was a parallel-group, phase 3, multicentre, randomised, controlled trial done in 22 radiotherapy centres in Ireland and the UK. Participants were aged 18 years and older, had T1-4, N0-3, M0 oroph... From June 24, 2016, to April 27, 2018, 118 patients were registered, 112 of whom were randomly assigned (56 to each treatment group). 22 (20%) participants were female and 90 (80%) were male; median a... Our findings suggest that DO-IMRT improves patient-reported swallowing function compared with standard IMRT. DO-IMRT should be considered a new standard of care for patients receiving radiotherapy for... Cancer Research UK....

Humans Male Female Middle Aged Radiotherapy, Intensity-Modulated +4 autres

Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy.

10 2022

DOI: 10.1200/OP.22.00104 PMID: 35930751

Delays in initiation of radiotherapy may contribute to inferior oncologic outcomes that are more commonly observed in minoritized populations in the United States. We aimed to examine inequities assoc... The National Cancer Database was queried to identify the 10 cancer sites most commonly treated with IMRT. Interval to initiation of treatment (IIT) was broken into quartiles for each disease site, wit... Among patients (n = 350,425) treated with IMRT between 2004 and 2017, non-Hispanic Black (NHB), Hispanic, and Asian patients were significantly more likely to have delayed IIT with IMRT for nearly all... Delays in initiation of IMRT in NHB, Hispanic, and Asian patients may contribute to the known differences in cancer outcomes and warrant further investigation, particularly to further clarify the role...

Black or African American Aged Hispanic or Latino Humans Medicare +3 autres

Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.

01 Nov 2023

DOI: 10.31557/APJCP.2023.24.11.3697 PMID: 38019227

Dosimetric sparing of critical swallowing structures like constrictor muscles and larynx can lead to improved functional outcomes in head and neck cancer patients treated by chemoradiation.... A total of 50 Patients with newly diagnosed, biopsy proven AJCC stage II-IV head and neck squamous cell cancers (HNSCC) were prospectively studied. 25 patients were randomized in each arm of Dysphagia... Patients in both arms showed significant (P <0.01 or P < 0.001) improvement in MDADI (global and composite), UW-QOL and Water Swallow Test scores. However, the improvements were found significantly hi... The Do-IMRT improves swallowing functions compared to S-IMRT in HNSCC patients treated with radical chemoradiation....

Humans Deglutition Disorders Radiotherapy, Intensity-Modulated Squamous Cell Carcinoma of Head and Neck Quality of Life +2 autres

Concurrent chemoradiotherapy versus radiotherapy alone for stage II nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Jul 2023

DOI: 10.1007/s00405-023-07943-9 PMID: 37079074

Concurrent chemoradiotherapy has long been a standardized therapy for localized advanced nasopharyngeal cancer. It is widely used in clinical applications. In contrast, NCCN guidelines highlight that ... We searched the relevant literature in PubMed, EMBASE, and Cochrane, extracting relevant data from the searched literature. The main items extracted were hazard ratios (HRs), risk ratios (RRs) and 95%... Our study included seven articles involving 1633 cases of stage II nasopharyngeal cancer. The survival outcomes were overall survival (OS) (HR = 1.03, 95% CI (0.71-1.49), P = 0.87), progression-free s... In the era of intensity-modulated radiotherapy, concurrent chemoradiotherapy and radiotherapy alone have the same survival benefits, and concurrent chemoradiotherapy increases acute hematological toxi...

Humans Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms Radiotherapy, Intensity-Modulated Disease-Free Survival +3 autres

Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?

Nov 2022

DOI: 10.1007/s00405-022-07452-1 PMID: 35598230

A planning study was performed to evaluate dosimetric differences between intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for head and neck cancer (HNC) for se... 30 patients with HNC were included, 15 treated with SIB and 15 with Seq-Boost. For all patients both VMAT and IMRT plans were completed. The planning objective for PTV was 95% of dose covering minimum... Both techniques achieved the set objectives regarding PTV coverage and organ sparing. SIB plans presented a statistically significant better homogeneity for VMAT (p = 0.0096), while Seq-boost showed a... VMAT shows dosimetric superiority to IMRT in some cases, however an adequate coverage of the target volumes and a suitable OAR sparing can be achieved with both techniques. Though IMRT is still the st...

Head and Neck Neoplasms Humans Radiometry Radiotherapy Dosage Radiotherapy Planning, Computer-Assisted +1 autres

Favorable outcome in advanced pheochromocytoma and paraganglioma after hypofractionated intensity modulated radiotherapy.

Mar 2023

DOI: 10.1007/s40618-022-01908-1 PMID: 36121637

The purpose of this study was to review outcomes of patients with advanced/metastatic pheochromocytoma/paraganglioma (PPGL) treated at our institution with Intensity-modulated radiotherapy (IMRT), des... A retrospective study on patients with advanced/metastatic PPGL who received IMRT at Peking Union Medical College Hospital between 2014 and 2019. A total of 14 patients with 17 lesions were included i... OS at 2 years was 78% for all patients. For lesions evaluated by RECIST response, at least stable disease of the target lesion was achieved in 94% and distant progression in 28.5%, with an average tim... We have found hypofractionated IMRT effective as an additional therapy for patients with advanced primary tumors or recurrence in situ and not amenable to complete surgical resection....

Humans Radiotherapy, Intensity-Modulated Pheochromocytoma Retrospective Studies Treatment Outcome +3 autres

Intensity-modulated radiotherapy for cushing's disease: single-center experience in 70 patients.

2023

DOI: 10.3389/fendo.2023.1241669 PMID: 37822603

Intensity-modulated radiotherapy (IMRT) is a modern precision radiotherapy technique for the treatment of the pituitary adenoma.... Aim to investigate the efficacy and toxicity of IMRT in treating Cushing's Disease (CD).... 70 of 115 patients with CD treated with IMRT at our institute from April 2012 to August 2021 were included in the study. The radiation doses were usually 45-50 Gy in 25 fractions. After IMRT, endocrin... At a median follow-up time of 36.8 months, the endocrine remission rate at 1, 2, 3 and 5 years were 28.5%, 50.2%, 62.5% and 74.0%, respectively. The median time to remission was 24 months (95%CI: 14.0... IMRT was a highly effective second-line therapy with low side effect profile for CD patients. Endocrine remission, tumor control and recurrence rates were comparable to previous reports on FRT and SRS...

Humans Pituitary ACTH Hypersecretion Radiotherapy, Intensity-Modulated Treatment Outcome Pituitary Neoplasms +1 autres

Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy.

01 2023

DOI: 10.1002/cam4.5020 PMID: 35822664

We analyzed the patterns of lymph node (LN) failure and prognosis in patients with regional recurrent nasopharyngeal carcinoma (rNPC) alone after primary intensity-modulated radiotherapy (IMRT).... A total of 175 patients who were treated with IMRT between 2010 and 2015 and who experienced regional recurrence alone were included. Recurrent LNs were re-located in the initial pretreatment imaging ... Level IIb (49.1%, 86/175) was the most frequent recurrence site, followed by level IIa (36%), level III (18.9%), level IVa (12%), the retropharyngeal region (8%), level Va (6.9%), and the parotid regi... In-field failure represented the main pattern of regional recurrence and out-field failure mainly occurred in the parotid gland and level Ib. Patients with regional rNPC alone had a good prognosis aft...

Humans Nasopharyngeal Carcinoma Radiotherapy, Intensity-Modulated Nasopharyngeal Neoplasms Epstein-Barr Virus Infections +6 autres

Maladies vasculaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Anévrysme

Faux anévrisme

Angiodysplasie

Angiomatose

Maladies de l'aorte

Artériopathies oblitérantes

Syndrome de fuite capillaire

Angiopathies intracrâniennes

Colite ischémique

Syndrome des loges

Embolie et thrombose

Hémorroïdes

Maladie veno-occlusive hépatique

Hyperhémie

Hypertension artérielle

Hypotension artérielle

Ischémie mésentérique

Ischémie myocardique

Neuropathie optique ischémique

Péliose hépatique

Ulcère athérosclérotique pénétrant

Maladies vasculaires périphériques

Préhypertension

Maladie veino-occlusive pulmonaire

Occlusion veineuse rétinienne

Maladies vasculaires de la moelle épinière

Sténose de la veine pulmonaire

Syndrome de la veine cave supérieure

Télangiectasie

Syndrome du défilé thoracobrachial

Varicocèle

Varices

Tumeurs vasculaires

Vascularite

Insuffisance veineuse

Anévrysme infectieux

Rupture d'anévrysme

Dissection vasculaire

Anévrysme cardiaque

Anévrysme de l'artère iliaque

Microanévrisme

Anévrisme de l'artère poplitée

Ectasie vasculaire antrale

Syndrome de Klippel-Trénaunay

Syndrome de Sturge-Weber

Syndrome aortique aigu

Anévrysme de l'aorte

Syndromes de la crosse aortique

Artériosclérose

Dysplasie fibromusculaire

Syndrome de Leriche

Occlusion vasculaire mésentérique

Le syndrome de l'artère poplitée piégée

Occlusion artérielle rénale

Occlusion artérielle rétinienne

Sténose de l'artère pulmonaire

Angiopathies des ganglions de la base

Encéphalopathie ischémique

Artériopathies carotidiennes

Maladies des petits vaisseaux cérébraux

Artériopathies intracrâniennes

Accident vasculaire cérébral

Céphalées vasculaires

Vasospasme intracrânien

Syndrome de la loge tibiale antérieure

Hypertension intra-abdominale

Contracture ischémique

Embolie

Thromboembolie